Wednesday, May 06, 2020 1:05:12 PM
Refreshing to hear about the IPF and CC ethics approval in Australia. Enrollment begins in June. Another trial in the works with high potential to yield valuable data. Currently no CC drug on the market and only Bellus Health has a drug in phase 2 trials. Their trials are currently on hold for obvious reasons. Everything is going swimmingly and things continue to unfold for Algernon.
Cash on deck to ensure funding is there without waiting on grants or government handouts. I would take a private placement and ensure we keep our timelines every day of the week than to slow down our progress and wait for governments to see our true potential and give us funding. The latter is way too risky in losing momentum in this fight. Positive phase 2 COVID 19 data readouts in multiple countries? You better believe that if and when that happens money will be thrown and hurled at us from a myriad of directions.
Go Chris and Mark! Keep up the solid work. We are on the home stretch here guys.
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM
ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM
Fifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates • CAFI • Jun 13, 2024 8:45 AM